Skip to main content

Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.

Publication ,  Journal Article
Hung, S-I; Chung, W-H
Published in: Neurology
April 23, 2013

Duke Scholars

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

April 23, 2013

Volume

80

Issue

17

Start / End Page

1621

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • Male
  • Humans
  • HLA-B15 Antigen
  • Genetic Testing
  • Female
  • Epilepsy
  • Decision Making
  • 3209 Neurosciences
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hung, S.-I., & Chung, W.-H. (2013). Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. Neurology, 80(17), 1621. https://doi.org/10.1212/WNL.0b013e3182915be2
Hung, Shuen-Iu, and Wen-Hung Chung. “Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.Neurology 80, no. 17 (April 23, 2013): 1621. https://doi.org/10.1212/WNL.0b013e3182915be2.
Hung, Shuen-Iu, and Wen-Hung Chung. “Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.Neurology, vol. 80, no. 17, Apr. 2013, p. 1621. Pubmed, doi:10.1212/WNL.0b013e3182915be2.

Published In

Neurology

DOI

EISSN

1526-632X

Publication Date

April 23, 2013

Volume

80

Issue

17

Start / End Page

1621

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • Male
  • Humans
  • HLA-B15 Antigen
  • Genetic Testing
  • Female
  • Epilepsy
  • Decision Making
  • 3209 Neurosciences
  • 3202 Clinical sciences